Skip to content
April 20, 2024

Equity.Guru

Investment information for the new generation

Search

rotigotine

Xphyto Therapeutics (XPHY.C) provided a market and product update on its Rotigotine transdermal (TDS) patch, originally developed by their German subsidiary, Vektor Pharma TF GmbH. If you’re interested in…
XPhyto Therapeutics (XPHY.C), a bioscience accelerator in the life science industry, announced today that its drug formulation programs are advancing on schedule and continue to expand in scope. “Vektor…